235 related articles for article (PubMed ID: 23276383)
1. Canine splenic haemangiosarcoma: influence of metastases, chemotherapy and growth pattern on post-splenectomy survival and expression of angiogenic factors.
Göritz M; Müller K; Krastel D; Staudacher G; Schmidt P; Kühn M; Nickel R; Schoon HA
J Comp Pathol; 2013 Jul; 149(1):30-9. PubMed ID: 23276383
[TBL] [Abstract][Full Text] [Related]
2. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
[TBL] [Abstract][Full Text] [Related]
3. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
[TBL] [Abstract][Full Text] [Related]
5. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
Bray JP; Orbell G; Cave N; Munday JS
J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
[TBL] [Abstract][Full Text] [Related]
6. Littoral cell angiosarcoma in a dog.
Gal A; Yamate J; Golbar HM; Spoerer K; Fredrickson R
J Comp Pathol; 2013; 149(2-3):221-4. PubMed ID: 23453493
[TBL] [Abstract][Full Text] [Related]
7. Association between macroscopic appearance of liver lesions and liver histology in dogs with splenic hemangiosarcoma: 79 cases (2004-2009).
Clendaniel DC; Sivacolundhu RK; Sorenmo KU; Donovan TA; Turner A; Arteaga T; Bergman PJ
J Am Anim Hosp Assoc; 2014; 50(4):e6-10. PubMed ID: 25001171
[TBL] [Abstract][Full Text] [Related]
8. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes.
Stewart SD; Ehrhart EJ; Davies R; Khanna C
Vet Comp Oncol; 2020 Dec; 18(4):811-817. PubMed ID: 32458544
[TBL] [Abstract][Full Text] [Related]
9. Impact of repeated cycles of EGF bispecific angiotoxin (eBAT) administered at a reduced interval from doxorubicin chemotherapy in dogs with splenic haemangiosarcoma.
Borgatti A; Fieberg A; Winter AL; Stuebner K; Taras E; Todhunter D; Masyr A; Rendhal A; Vallera DA; Koopmeiners JS; Modiano JF
Vet Comp Oncol; 2020 Dec; 18(4):664-674. PubMed ID: 32187827
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor in dogs with haemangiosarcoma and haematoma.
Frenz M; Kaup FJ; Neumann S
Res Vet Sci; 2014 Oct; 97(2):257-62. PubMed ID: 25241388
[TBL] [Abstract][Full Text] [Related]
11. Gastric dilatation-volvulus as complication after surgical removal of a splenic haemangiosarcoma in a dog.
Marconato L
J Vet Med A Physiol Pathol Clin Med; 2006 Sep; 53(7):371-4. PubMed ID: 16922836
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma.
Adachi M; Hoshino Y; Izumi Y; Takagi S
J Vet Med Sci; 2016 May; 78(4):649-56. PubMed ID: 26685984
[TBL] [Abstract][Full Text] [Related]
13. Splenic angiosarcoma: a clinicopathologic and immunophenotypic study of 28 cases.
Neuhauser TS; Derringer GA; Thompson LD; Fanburg-Smith JC; Miettinen M; Saaristo A; Abbondanzo SL
Mod Pathol; 2000 Sep; 13(9):978-87. PubMed ID: 11007038
[TBL] [Abstract][Full Text] [Related]
14. [Hemangiosarcoma of the spleen: clinical aspects in 52 dogs].
Kessler M; Maurus Y; Köstlin R
Tierarztl Prax Ausg K Kleintiere Heimtiere; 1997 Nov; 25(6):651-6. PubMed ID: 9459832
[TBL] [Abstract][Full Text] [Related]
15. A comparison of microRNA expression profiles from splenic hemangiosarcoma, splenic nodular hyperplasia, and normal spleens of dogs.
Grimes JA; Prasad N; Levy S; Cattley R; Lindley S; Boothe HW; Henderson RA; Smith BF
BMC Vet Res; 2016 Dec; 12(1):272. PubMed ID: 27912752
[TBL] [Abstract][Full Text] [Related]
16. Refining the "double two-thirds" rule: Genotype-based breed grouping and clinical presentation help predict the diagnosis of canine splenic mass lesions in 288 dogs.
Davies O; Taylor AJ
Vet Comp Oncol; 2020 Dec; 18(4):548-558. PubMed ID: 32043696
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hemangiosarcoma in anemic dogs with a splenic mass and hemoperitoneum requiring a transfusion: 71 cases (2003-2005).
Hammond TN; Pesillo-Crosby SA
J Am Vet Med Assoc; 2008 Feb; 232(4):553-8. PubMed ID: 18279091
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic splenectomy for treatment of splenic hemangiosarcoma in a dog.
Collard F; Nadeau ME; Carmel EN
Vet Surg; 2010 Oct; 39(7):870-2. PubMed ID: 20723196
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical demonstration of angiogenesis-associated homeobox proteins in canine vascular tumours.
Kodama A; Sakai H; Murakami M; Murai A; Mori T; Maruo K; Yanai T; Masegi T
J Comp Pathol; 2009; 141(2-3):199-203. PubMed ID: 19505696
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII-related antigen in canine endothelial neoplasms: an immunohistochemical study.
von Beust BR; Suter MM; Summers BA
Vet Pathol; 1988 Jul; 25(4):251-5. PubMed ID: 3136585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
